Filing Details

Accession Number:
0001209191-21-053210
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-24 18:07:10
Reporting Period:
2021-08-20
Accepted Time:
2021-08-24 18:07:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1326110 Immunitybio Inc. IBRX Biological Products, (No Disgnostic Substances) (2836) 431979754
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1529371 Cheryl Cohen C/O Immunitybio, Inc.
3530 John Hopkins Court
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-08-20 9,976 $10.00 215,418 No 4 S Direct
Common Stock Disposition 2021-08-23 14,801 $10.12 200,617 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on May 13, 2021.
  2. Represents the weighted average share price of an aggregate total of 9,976 shares sold in the price range of $10.00 to $10.02 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. Represents the weighted average share price of an aggregate total of 14,801 shares sold in the price range of $10.02 to $10.27 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.